Zika virus E protein ectodomain polyclonal antibody
Product Specifications
Background
Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (Family Flaviviridae) and was first described in 1947 in Uganda following blood analyses of sentinelRhesusmonkeys1. Until the 20thcentury, the African and Asian lineages of the virus did not cause meaningful infections in humans. However, in 2007, vectored byAedes aegyptimosquitoes, ZIKV caused the first noteworthy epidemic on the island of Yap in Micronesia2. Patients experienced fever, skin rash, arthralgia and conjunctivitis2. Zika is spread mostly by the bite of an infected Aedes species mosquito (Ae. aegypti and Ae. albopictus) . These mosquitoes bite during the day and night. Zika can be passed from a pregnant woman to her fetus. Infection during pregnancy can cause certain birth defects. There is no vaccine or medicine for Zika.
CAS Number
9007-83-4
Structure Composition
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2.
Swiss Prot
KU744693.1
Reactivity
ZIKV-E
Immunogen
Recombinant protein of ZIKV-E.
Conjugation
Unconjugated
Applications
WB ELISA
Dilution
WB: 1:500~1:2000 ELISA: 1:5000~10000
Purity
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .
Modification
Unmodification
Storage Conditions
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Notes
For research use only, not for use in diagnostic procedure.
Specificity
Zika virus E protein ectodomain polyclonal antibody detects endogenous levels of ZIKV-E protein.
Host or Source
Rabbit
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P1794-57E-ML750 100 µL
PAD4, CT (Protein-arginine Deiminase Type IV, Protein-arginine Deiminase Type-4, Peptidylarginine Deiminase IV, HL-60 PAD, PADI4, PADI5, PDI5) (MaxLight 750) discontinued
Sign In for Pricing
View Details